Keurig Dr Pepper Inc. (VIE:KDP)
Austria · Delayed Price · Currency is EUR | Market Cap | 37.24B +10.4% |
| Revenue (ttm) | 17.58B +27.5% |
| Net Income | 1.18B -7.1% |
| EPS | 0.87 -12.3% |
| Shares Out | n/a |
| PE Ratio | 31.63 |
| Forward PE | 12.61 |
| Dividend | 0.79 (2.89%) |
| Ex-Dividend Date | Jun 26, 2026 |
| Volume | n/a |
| Open | 27.61 |
| Previous Close | 27.59 |
| Day's Range | 27.53 - 27.90 |
| 52-Week Range | 21.55 - 29.39 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2026 |
About Keurig Dr Pepper
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. The company operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. It manufactures and distributes branded concentrates, syrup, and finished beverages, as well as sales of owned brands and third-party brands; tea, cocoa, and other products; and offers finished goods relating to K-Cup pods, single serve brewers, specialty coffee, and ready to drink coffee products. T... [Read more]
Financial Performance
In 2025, Keurig Dr Pepper's revenue was $16.60 billion, an increase of 8.16% compared to the previous year's $15.35 billion. Earnings were $2.08 billion, an increase of 44.27%.
Financial numbers in USD Financial StatementsNews
Coffee Prices Are High. Why Ground Coffee Is Holding Up Better Than K-Cups.
Raw coffee costs have eased from last year's highs, but remain historically elevated.
Keurig Dr Pepper to Participate in Barclays Global Consumer Staples Conference
FRISCO, Texas and BURLINGTON, Mass., Aug. 27, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today announced that Tim Cofer, Chief Executive Officer, and Anthony DiSilvestro, Chief Financial...
Keurig Dr Pepper resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian resumed coverage of Keurig Dr Pepper (KDP) with an Overweight rating and $38 price target The stock’s “discounted valuation: does not reflect Keurig’s solid North...
Keurig Dr Pepper appoints Aaron Alt to board of directors
Keurig Dr Pepper (KDP) announced that Aaron Alt has been appointed a director of the company’s Board of Directors, effective August 14. Alt brings deep expertise in finance, capital allocation…
Keurig Dr Pepper upgraded to Buy from Hold at HSBC
HSBC upgraded Keurig Dr Pepper (KDP) to Buy from Hold with a $40 price target
Keurig Dr Pepper jumps after HSBC upgrades on beverage trends
As previously reported, HSBC upgraded Keurig Dr Pepper (KDP) to Buy from Hold with a price target of $40, up from $37. The stock in midday trading is up 5%,…
Keurig Dr Pepper Announces Appointment of New Director to its Board
FRISCO, Texas and BURLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today that Aaron Alt has been appointed a director of the Company's Board of Directors,...
7UP Puts Lime in the Spotlight With Its Biggest Brand Evolution in More Than 15 Years
The best-tasting 7UP ever combines the lime-forward profile consumers preferred most with a refreshed identity that challenges convention in the lemon-lime category FRISCO, Texas, Aug. 10, 2026 /PRNew...
Keurig Dr Pepper price target raised to $38 from $36 at Barclays
Barclays raised the firm’s price target on Keurig Dr Pepper (KDP) to $38 from $36 and keeps an Overweight rating on the shares. The firm says the integration of JDE…
Keurig Dr Pepper price target raised to $39 from $38 at UBS
UBS raised the firm’s price target on Keurig Dr Pepper (KDP) to $39 from $38 and keeps a Buy rating on the shares.
Keurig Dr Pepper price target raised to $32 from $30 at Evercore ISI
Evercore ISI raised the firm’s price target on Keurig Dr Pepper (KDP) to $32 from $30 and keeps an In Line rating on the shares.
Keurig Dr Pepper Earnings Call Transcript: Q2 2026
Q2 2026 saw net sales surge 74.6% year-over-year, driven by the JDE Peet's acquisition and strong U.S. Refreshment Beverages performance. EPS rose 16.3% to $0.57, and the company reaffirmed its full-year guidance for low double-digit EPS growth and robust free cash flow.
Keurig Dr Pepper Earnings release: Q2 2026
Keurig Dr Pepper released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Keurig Dr Pepper Slides: Q2 2026
Keurig Dr Pepper has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Keurig Dr Pepper Quarterly report: Q2 2026
Keurig Dr Pepper has published its Q2 2026 quarterly earnings report on August 6, 2026.
Keurig Dr Pepper Posts Higher Sales as Separation Work Continues
Keurig Dr Pepper logged higher sales in the second quarter and said it continues work to separate into two companies.
Keurig Dr Pepper reaffirms forecast on strong soda, energy drink demand
Keurig Dr Pepper on Thursday left its annual forecasts unchanged after beating analysts' estimates for second-quarter sales and profit, helped by strength in its sodas and energy drinks portfolios, e...
Keurig Dr Pepper reports Q2 adjusted EPS 57c, consensus 54c
Reports Q2 revenue $7.31B, consensus $7.23B. Commenting on the performance, CEO Tim Cofer stated, “We delivered another strong quarter of results, with Q2 EPS exceeding our expectations. U.S. Refreshm...
Keurig Dr Pepper backs FY26 revenue $25.9B-$26.4B, consensus $26.26B
For 2026, KDP expects net sales of $25.9B-$26.4B and constant currency adjusted diluted EPS growth in a low-double-digit range. This guidance is comprised of 4%-6% constant currency net sales growth…
Keurig Dr Pepper Reports Q2 Results and Reaffirms Guidance for 2026
Performance Led by U.S. Refreshment Beverages and JDE Peet's Company Reaffirms 2026 Constant Currency Net Sales and Adjusted EPS Outlook Company Continues to Target a Pro-Forma Management Leverage Rat...
Keurig Dr Pepper price target raised to $38 from $33 at JPMorgan
JPMorgan raised the firm’s price target on Keurig Dr Pepper (KDP) to $38 from $33 and keeps an Overweight rating on the shares. The firm believes investors are warming up…
Micron, Keurig Dr Pepper added to ‘US 1 List’ at BofA
BofA analysts added Micron (MU) and Keurig Dr Pepper (KDP) to the firm’s US 1 List, a collection of its best investment ideas.
Keurig Dr Pepper price target raised to $38 from $34 at UBS
UBS analyst Peter Grom raised the firm’s price target on Keurig Dr Pepper (KDP) to $38 from $34 and keeps a Buy rating on the shares.
Keurig Dr Pepper price target raised to $37 from $32 at Citi
Citi analyst Filippo Falorni raised the firm’s price target on Keurig Dr Pepper (KDP) to $37 from $32 and keeps a Buy rating on the shares. The firm adjusted targets…
Keurig Dr Pepper added to Q3 Tactical Ideas List at Wells Fargo
Wells Fargo is adding Keurig Dr Pepper (KDP) to the firm’s Q3 Tactical Ideas List. While shares have seen momentum since its recent tactical call on the stock, Wells believes…